UCLA Medical Center, Santa Monica

UCLA Health

Santa Monica, CA

Sorting 2 by

Accepting patients

QUINTESSENTIAL-2

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma
Learn more
  • CAR T Cell
  • GPRC5D
  • Randomization
  • Phase 3

Not yet accepting

Cemsidomide in Combination With Elranatamab

A Phase 1B, Open-label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Learn more
  • IKZF1/3
  • Phase 1